BE751667A - Complexe prothrombine - Google Patents

Complexe prothrombine

Info

Publication number
BE751667A
BE751667A BE751667DA BE751667A BE 751667 A BE751667 A BE 751667A BE 751667D A BE751667D A BE 751667DA BE 751667 A BE751667 A BE 751667A
Authority
BE
Belgium
Prior art keywords
prothrombin complex
prothrombin
complex
Prior art date
Application number
Other languages
English (en)
Inventor
Lajos F Fekete
Edward Shanbrom
L F Fekete
E Shanbrom
Original Assignee
Baxter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Laboratories Inc filed Critical Baxter Laboratories Inc
Publication of BE751667A publication Critical patent/BE751667A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
BE751667D 1969-06-19 1970-06-09 Complexe prothrombine BE751667A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83488369A 1969-06-19 1969-06-19

Publications (1)

Publication Number Publication Date
BE751667A true BE751667A (fr) 1970-11-16

Family

ID=25268043

Family Applications (1)

Application Number Title Priority Date Filing Date
BE751667D BE751667A (fr) 1969-06-19 1970-06-09 Complexe prothrombine

Country Status (13)

Country Link
US (1) US3560475A (fr)
BE (1) BE751667A (fr)
CA (1) CA920058A (fr)
DE (1) DE2029455C3 (fr)
DK (1) DK127676B (fr)
ES (1) ES380950A1 (fr)
FR (1) FR2052987B1 (fr)
GB (1) GB1253339A (fr)
IL (1) IL34599A (fr)
IT (1) IT1043810B (fr)
NL (1) NL170150C (fr)
SE (1) SE397474B (fr)
ZA (1) ZA703574B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0823476A3 (fr) * 1996-08-09 1999-09-01 Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute Procédé pour activer prothrombine à thrombine

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803115A (en) * 1972-05-17 1974-04-09 Baxter Laboratories Inc Stabilization of ahf using heparin
US4073886A (en) * 1973-01-30 1978-02-14 Baxter Travenol Laboratories, Inc. Blood fractionation process using block copolymers of ethylene oxide and polyoxypropylene
US3956259A (en) * 1973-01-30 1976-05-11 Baxter Laboratories, Inc. Fractionation of blood using block copolymer of ethylene oxide and polyoxypropylene polymer to recover fraction suitable for organ perfusate
US4025500A (en) * 1974-06-06 1977-05-24 Baxter Laboratories, Inc. Preparation of albumin by fractionation of blood plasma or serum
US4001401A (en) * 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
US4046877A (en) * 1975-07-18 1977-09-06 Syntex (U.S.A.) Inc. Method of increasing immunologic competence
DK144731C (da) 1976-07-30 1982-10-18 Nordisk Insulinlab Fremgangsmaade til isolering af proteinhormoner stammende fra humant hypofysevaev
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
FR2472390A1 (fr) * 1979-05-04 1981-07-03 Merieux Inst Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus
US4287180A (en) * 1980-01-28 1981-09-01 Baxter Travenol Laboratories, Inc. Method for treating blood clotting factor inhibitors
WO1981002105A1 (fr) * 1980-01-28 1981-08-06 Baxter Travenol Lab Compositions therapeutiques et procede de fabrication et d'utilisation de celles-ci
US4286056A (en) * 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
US4404132A (en) * 1980-05-27 1983-09-13 Cutter Laboratories, Inc. Blood coagulation promoting product
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
US4361510A (en) * 1980-05-27 1982-11-30 Cutter Laboratories, Inc. Blood coagulation promoting product
US4391746A (en) * 1980-05-27 1983-07-05 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
US4479938A (en) * 1981-06-25 1984-10-30 Baxter Travenol Laboratories, Inc. Therapeutic composition containing factor VIIa
US4382083A (en) * 1981-06-25 1983-05-03 Baxter Travenol Laboratories, Inc. Therapeutic method for treating blood-clotting defects with factor VIIa
US5055557A (en) * 1983-03-04 1991-10-08 Scripps Clinic & Research Foundation Ultrapurification of factor IX and other vitamin K-dependent proteins
US5614500A (en) * 1983-03-04 1997-03-25 The Scripps Research Institute Compositions containing highly purified factor IX proteins prepared by immunoaffinity chromatography
US4786726A (en) * 1986-01-06 1988-11-22 Blood Systems, Inc. Factor IX therapeutic blood product, means and methods of preparing same
ZA877535B (en) * 1986-10-09 1988-04-11 F. Hoffmann-La Roche & Co. Aktiengesellschaft Factor ix-peptides
USH1509H (en) * 1989-06-09 1995-12-05 Eran; Harutyun Heparin enhanced process for separating antihemophilic factor (Factor VIII) and fibronectin from cryoprecipitate
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US5925738A (en) * 1995-12-01 1999-07-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
USRE38431E1 (en) * 1995-12-01 2004-02-17 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
US6320029B1 (en) 1996-11-29 2001-11-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
US5770705A (en) * 1996-11-01 1998-06-23 Shanbrom Technologies Llc Method for recovering proteins from plasma using insoluble, water-absorbing material
US8389687B2 (en) * 2000-10-23 2013-03-05 Shanbrom Technologies, Llc Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors
US7411006B2 (en) * 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
US7297716B2 (en) * 2000-10-23 2007-11-20 Shanbrom Technologies, Llc Enhanced production of blood components, blood cells and plasma without freezing
DE602005024955D1 (de) 2004-03-19 2011-01-05 Baxter Healthcare Sa Faktor ixa zur behandlung von blutungsstörungen
CN116194080A (zh) 2020-09-23 2023-05-30 奥姆里克斯生物药品有限公司 止血制剂及其用途

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0823476A3 (fr) * 1996-08-09 1999-09-01 Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute Procédé pour activer prothrombine à thrombine

Also Published As

Publication number Publication date
GB1253339A (en) 1971-11-10
DK127676B (da) 1973-12-17
FR2052987A1 (fr) 1971-04-16
NL170150B (nl) 1982-05-03
DE2029455B2 (de) 1978-08-24
US3560475A (en) 1971-02-02
ZA703574B (en) 1971-01-27
IL34599A (en) 1973-07-30
DE2029455C3 (de) 1979-04-19
SE397474B (sv) 1977-11-07
IT1043810B (it) 1980-02-29
DE2029455A1 (de) 1971-02-25
FR2052987B1 (fr) 1974-05-24
IL34599A0 (en) 1970-07-19
NL170150C (nl) 1982-10-01
CA920058A (en) 1973-01-30
ES380950A1 (es) 1972-10-16
NL7008957A (fr) 1970-12-22

Similar Documents

Publication Publication Date Title
BE751667A (fr) Complexe prothrombine
BE751784R (fr) Draaiknop
BE745669A (fr) Pulserend verbrandingssysteem
BE744024A (fr) Manipulateur-synthetiseur
BE752089A (fr) Benzimidazoolcarbamaten
BE749371A (fr) Spectrofotometer
BE751497A (fr) Rejeteaux
BE748852A (fr) Audio-moniteur
BE750639A (fr) Tetrahydropyranols
BE744146A (fr) Adhesifs
BE752426A (fr) Fotochrome polycondensaten
BE753958A (fr) 11-aminoalkylidenemorphanthridines
BE750202A (de) Zelfklevend sluitetiket
BE747783R (fr) Elektrofotografisch
BE747903A (fr) Spectraal gesensibiliseerd lichtgevoelig materiaal
BE750756A (fr) Photocomposeuse
BE752151A (fr) Filmcassette
BE752854A (fr) Beta-mercapto-gesubstitueerde alifatische nitrillen
BE749943A (fr) Zuurkast
BE747782A (fr) Fotografisch veellagenkleurenmateriaal
BE749878A (fr) Volumemeters
BE746342A (fr) Merocyanine-kleurstoffen
AT324166B (de) Sportschuh
BE747776A (fr) Bigoudi
BE752419A (fr) N-phenacylcarbamates

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BAXTER LABORATORIES INC.

Effective date: 19850609